Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Larsen, Stephen R  [Clear All Filters]
Journal Article
Nield B, Larsen SR, van Hal SJ. Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies. J Antimicrob Chemother. 2019.
McErlean G, Tapp C, Brice L, Pradhan A, Gilroy N, Kabir M, Greenwood M, Larsen SR, Moore J, Gottlieb D, et al. Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional Survey. Clin Nurs Res. 2023:10547738231180337.
Brice L, McErlean G, Donovan C, Tapp C, Gilroy N, Kabir M, Greenwood M, Larsen SR, Moore J, Gottlieb D, et al. Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study. Eur J Oncol Nurs. 2020;49:101845.
Coutsouvelis J, Kirkpatrick CM, Dooley M, Spencer A, Kennedy G, Chau M, Huang G, Doocey R, Copeland T-S, Do L, et al. Incidence of sinusoidal obstruction syndrome/veno-occlusive disease and treatment with defibrotide in allogeneic transplant: A multicentre Australasian registry study. Transplant Cell Ther. 2023.
McErlean G, Tapp C, Brice L, Gilroy N, Kabir M, Greenwood M, Larsen SR, Moore J, Gottlieb D, Hertzberg M, et al. Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey. BMC Psychol. 2023;11(1):235.
Dyer G, Gilroy N, Brice L, Kabir M, Gottlieb D, Huang G, Hogg M, Brown L, Greenwood M, Larsen SR, et al. A survey of infectious diseases and vaccination uptake in long-term Haematopoietic Stem Cell Transplant survivors in Australia. Transpl Infect Dis. 2018:e13043.
Abadir E, Silveira PA, Gasiorowski RE, Ramesh M, Romano A, Mekkawy AH, Lo T-H, Kabani K, Sutherland S, Pietersz GA, et al. Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia. Blood Adv. 2020;4(7):1206-1216.